🔗 Permalink

Inventor profile of:

HERMANN WAGNER

City:

ECHING

Country:

Germany

Published Applications:

Last publication date:

2014-11-20

Top Assignees for applications by HERMANN WAGNER

The entities that hold a legal rights for patent applications filed by inventor WAGNER HERMANN:

COLEY PHARMACEUTICAL GMBH 8 Langenfeld, Germany
COLEY PHARMACEUTICAL GMBH 3 DUSSELDORF, Germany
Amgen Inc. 2 Thousand Oaks, CA United States
Technische Universitat Munchen 2 Munich, Germany
Zoetis Belgium S.A 1 Louvain-La-Neuve, Belgium
Coley Pharmaceutical Group, Inc. 1 Wellesley, MA United States
Coley Pharmaceuticals GmbH 1 Langenfeld, Germany
Zoetis Belgium 1 Florham Park, NJ United States
Technische Universitaet Munchen 1 Muenchen, Germany
Technische Universitat Munchen 1 Muenchen, Germany

Recent patent applications by WAGNER HERMANN

HERMANN WAGNER from ECHING, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2014-11-20

US20140343256A1

Chemistry; metallurgy

TLR2 antagonistic antibody and use thereof

#2 | 2014-05-15

US20140135487A1

Chemistry; metallurgy

Immunostimulatory G, U-containing oligoribonucleotides

#3 | 2014-01-07

US10595204

TLR2 antagonistic antibody and use thereof

#4 | 2012-04-10

US10407952

Immunostimulatory G, U-containing oligoribonucleotides

#5 | 2009-03-05

US20090060927A1

Human necessities

Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination

#6 | 2008-05-15

US20080113929A1

Chemistry; metallurgy

Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist

#7 | 2007-08-09

US20070184465A1

Chemistry; metallurgy

Methods for regulating hematopoiesis using CpG-oligonucleotides

#8 | 2006-08-03

US20060172966A1

Chemistry; metallurgy

Immunostimulatory G, U-containing oligoribonucleotides

#9 | 2006-02-21

US9355254

Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination

#10 | 2005-09-13

US9954987

Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist

#11 | 2005-08-18

US20050181422A1

Chemistry; metallurgy

Process for high throughput screening of CpG-based immuno-agonist/antagonist

#12 | 2005-05-12

US20050100983A1

Chemistry; metallurgy

Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling

#13 | 2005-03-10

US20050054601A1

Human necessities

Pharmaceutical composition comprising a polynucleotide and optionally an antigen especially for vaccination

InventorID:

763774 ⎘